Eleonora Iuliano
Catanzaro, 88100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics.
Journal: Biomedicines
Published: April 13, 2022
Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune-Biological Evaluation and Case Report.
Journal: International journal of molecular sciences
Published: May 21, 2021
Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients.
Journal: Frontiers in immunology
Published: October 01, 2020
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis.
Journal: Cells
Published: July 20, 2020
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study.
Journal: Clinical pharmacology and therapeutics
Published: November 24, 2018
The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: June 09, 2018
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis.
Journal: Cancer chemotherapy and pharmacology
Published: September 28, 2015
miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.
Journal: Journal of cellular physiology
Published: November 30, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026